Taffy Makaya, Rebecca Poole and Kavitha Rozario
120
[53] Chanoine JP, Hampl S, Jensen C, Boldrin M; Hauptman J. 2005. ‘Effect
of orlistat on weight and body composition in obese adolescents: a
randomized controlled trial’. JAMA. 293(23):2873–83.
[54] Maahs D, de Serna DG, Kolotkin RL, Ralston S, Sandate J, Qualls C,
Schade DS. 2006. ‘Randomized, double-blind, placebo-controlled trial
of orlistat for weight loss in adolescents’. Endocr Pract. 12:18–28.
[55] Czernichow S, Lee CMY, Barzi F, Greenfield JR, Baur LA, Chalmers J,
Woodward M, Huxley RR. 2010. ‘Efficacy of weight loss drugs on
obesity and cardiovascular risk factors in obese adolescents: a meta-
analysis of randomized controlled trials’. Obes Rev. 11:150–8.
[56] Ozkan B, Bereket A, Turan S, Keskin S. 2004. ‘Addition of orlistat to
conventional treatment in adolescents with severe obesity’. Eur J
Pediatr. 163:738–741.
[57] Dolinsky DH, Armstrong SC, Kinra S. 2013. ‘The Clinical Treatment of
Childhood Obesity’. Indian l Pediatr. 80:S48-54.
[58] McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. 2002.
‘Effects of orlistat on fat-soluble vitamins in obese adolescents’.
Pharmacotherapy. 22:814–22.
[59] Norgen S, Danielsson P, Jurold R, Lötborn M, Marcus C. 2003. ‘Orlistat
treatment in obese prepubertal children: a pilot study’. Acta Paediatr.
92(6): 666-70.
[60] Dunn CJ, Peters DH. 1995. ‘Metformin. A review of its pharmacological
properties and therapeutic use in non-insulin dependent diabetes
mellitus’. Drugs. 49(5):721-49.
[61] Hsia Y, Dawoud D, Sutcliffe AG, Viner RM, Kinra S, Wong IC. 2012.
‘Unlicensed use of metformin in children and adolescents in the UK’. Br
J Clin Pharmacol. 73(1):135-9.
[62] Bouza C, Gutierrez L, Lopez-Cuadrado T. 2010. ‘Metformin for the
treatment of childhood obesity: A systematic review and meta-analysis’.
Value in Health. 13(7):1098-2015.
[63] Kendall D, Vail A, Amin R, Barrett T, Dimitri P, Ivison F, Kibirige M,
Mathew V, Matyka K, McGovern A, Stirling H, Tetlow L, Wales J,
Wright N, Clayton P, Hall C. 2013. ‘Metformin in Obese Children and
Adolescents: The MOCA Trial’. J Clin Endocrinol Metab. 98(1): 322-9.
[64] McDonagh MS, Selph S, Ozpinar A, Foley C. 2014. ‘Systematic review
of the benefits and risks of metformin in treating obesity in children aged
18 years and younger’. JAMA Pediatr. 168(2):178-84.